Cleveland BioLabs

$5.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.84%) Today
$0.00 (0.00%) As of 9:13 PM UTC after-hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, and ETFs commission-free!

About CBLI

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. The listed name for CBLI is Cleveland BioLabs, Inc. Common Stock.

CEO
Christopher Zosh
Employees
12
Headquarters
Buffalo, New York
Founded
2003
Market Cap
86.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.10M
High Today
$5.93
Low Today
$5.54
Open Price
$5.86
Volume
277.49K
52 Week High
$10.97
52 Week Low
$1.27

CBLI Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 14, After Hours

You May Also Like

DEEF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure